Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4 in the page history; this is a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.3 was added and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. These changes do not affect the study history content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page shows a new site revision tag, updating from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check67 days agoChange DetectedThe site-wide operating-status notice regarding government funding has been removed from the page.SummaryDifference0.5%

- Check81 days agoChange DetectedThe screenshots show a redesigned header and revised layout on the Record History page, while the version list and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check110 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference11%

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.